 | • レポートコード：D005-00644 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、黒色腫がんの世界市場を広く調査・分析し、今後の市場展望をまとめております。黒色腫がんの種類別市場規模（非侵襲性黒色腫、侵襲性黒色腫）、用途別市場規模（病院、がん研究センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：AB Sciences、Bristol-Myers Squibb、Novartis、Incyte、AstraZeneca、Merck、Amgen、Pierre Fabre、Daiichi Sankyo ・地域別グローバル市場分析 2015年-2020年 ・黒色腫がんの北米市場（アメリカ、カナダ、メキシコ） ・黒色腫がんのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・黒色腫がんのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・黒色腫がんの南米市場（ブラジル、アルゼンチン） ・黒色腫がんの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：非侵襲性黒色腫、侵襲性黒色腫 ・用途別分析：病院、がん研究センター ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Melanoma Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Melanoma Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Melanoma Cancer market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Melanoma Cancer market has been segmented into:
Non-invasive melanoma
Invasive melanoma
By Application, Melanoma Cancer has been segmented into:
Hospitals
Cancer Research Centers
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Melanoma Cancer market presented in the report. This section sheds light on the sales growth of different regional and country-level Melanoma Cancer markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Melanoma Cancer market.
The report offers in-depth assessment of the growth and other aspects of the Melanoma Cancer market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Melanoma Cancer Market Share Analysis
Melanoma Cancer competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Melanoma Cancer sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Melanoma Cancer sales, revenue and market share for each player covered in this report.
The major players covered in Melanoma Cancer are:
AB Sciences
Bristol-Myers Squibb
Novartis
Incyte
AstraZeneca
Merck
Amgen
Pierre Fabre
Daiichi Sankyo
Table of Contents
1 Melanoma Cancer Market Overview
1.1 Product Overview and Scope of Melanoma Cancer
1.2 Classification of Melanoma Cancer by Type
1.2.1 Global Melanoma Cancer Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Melanoma Cancer Revenue Market Share by Type in 2019
1.2.3 Non-invasive melanoma
1.2.4 Invasive melanoma
1.3 Global Melanoma Cancer Market by Application
1.3.1 Overview: Global Melanoma Cancer Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Cancer Research Centers
1.4 Global Melanoma Cancer Market by Regions
1.4.1 Global Melanoma Cancer Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Melanoma Cancer (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Melanoma Cancer Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Melanoma Cancer Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Melanoma Cancer Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Melanoma Cancer Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Melanoma Cancer Status and Prospect (2015-2025)
2 Company Profiles
2.1 AB Sciences
2.1.1 AB Sciences Details
2.1.2 AB Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AB Sciences SWOT Analysis
2.1.4 AB Sciences Product and Services
2.1.5 AB Sciences Melanoma Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bristol-Myers Squibb
2.2.1 Bristol-Myers Squibb Details
2.2.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bristol-Myers Squibb SWOT Analysis
2.2.4 Bristol-Myers Squibb Product and Services
2.2.5 Bristol-Myers Squibb Melanoma Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Melanoma Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.4 Incyte
2.4.1 Incyte Details
2.4.2 Incyte Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Incyte SWOT Analysis
2.4.4 Incyte Product and Services
2.4.5 Incyte Melanoma Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AstraZeneca SWOT Analysis
2.5.4 AstraZeneca Product and Services
2.5.5 AstraZeneca Melanoma Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck Melanoma Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.7 Amgen
2.7.1 Amgen Details
2.7.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Amgen SWOT Analysis
2.7.4 Amgen Product and Services
2.7.5 Amgen Melanoma Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pierre Fabre
2.8.1 Pierre Fabre Details
2.8.2 Pierre Fabre Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Pierre Fabre SWOT Analysis
2.8.4 Pierre Fabre Product and Services
2.8.5 Pierre Fabre Melanoma Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.9 Daiichi Sankyo
2.9.1 Daiichi Sankyo Details
2.9.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Daiichi Sankyo SWOT Analysis
2.9.4 Daiichi Sankyo Product and Services
2.9.5 Daiichi Sankyo Melanoma Cancer Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Melanoma Cancer Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Melanoma Cancer Players Market Share
3.2.2 Top 10 Melanoma Cancer Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Melanoma Cancer Revenue and Market Share by Regions
4.2 North America Melanoma Cancer Revenue and Growth Rate (2015-2020)
4.3 Europe Melanoma Cancer Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Melanoma Cancer Revenue and Growth Rate (2015-2020)
4.5 South America Melanoma Cancer Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Melanoma Cancer Revenue and Growth Rate (2015-2020)
5 North America Melanoma Cancer Revenue by Countries
5.1 North America Melanoma Cancer Revenue by Countries (2015-2020)
5.2 USA Melanoma Cancer Revenue and Growth Rate (2015-2020)
5.3 Canada Melanoma Cancer Revenue and Growth Rate (2015-2020)
5.4 Mexico Melanoma Cancer Revenue and Growth Rate (2015-2020)
6 Europe Melanoma Cancer Revenue by Countries
6.1 Europe Melanoma Cancer Revenue by Countries (2015-2020)
6.2 Germany Melanoma Cancer Revenue and Growth Rate (2015-2020)
6.3 UK Melanoma Cancer Revenue and Growth Rate (2015-2020)
6.4 France Melanoma Cancer Revenue and Growth Rate (2015-2020)
6.5 Russia Melanoma Cancer Revenue and Growth Rate (2015-2020)
6.6 Italy Melanoma Cancer Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Melanoma Cancer Revenue by Countries
7.1 Asia-Pacific Melanoma Cancer Revenue by Countries (2015-2020)
7.2 China Melanoma Cancer Revenue and Growth Rate (2015-2020)
7.3 Japan Melanoma Cancer Revenue and Growth Rate (2015-2020)
7.4 Korea Melanoma Cancer Revenue and Growth Rate (2015-2020)
7.5 India Melanoma Cancer Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Melanoma Cancer Revenue and Growth Rate (2015-2020)
8 South America Melanoma Cancer Revenue by Countries
8.1 South America Melanoma Cancer Revenue by Countries (2015-2020)
8.2 Brazil Melanoma Cancer Revenue and Growth Rate (2015-2020)
8.3 Argentina Melanoma Cancer Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Melanoma Cancer by Countries
9.1 Middle East & Africa Melanoma Cancer Revenue by Countries (2015-2020)
9.2 Saudi Arabia Melanoma Cancer Revenue and Growth Rate (2015-2020)
9.3 UAE Melanoma Cancer Revenue and Growth Rate (2015-2020)
9.4 Egypt Melanoma Cancer Revenue and Growth Rate (2015-2020)
9.5 South Africa Melanoma Cancer Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Melanoma Cancer Revenue and Market Share by Type (2015-2020)
10.2 Global Melanoma Cancer Market Forecast by Type (2019-2024)
10.3 Non-invasive melanoma Revenue Growth Rate (2015-2025)
10.4 Invasive melanoma Revenue Growth Rate (2015-2025)
11 Global Melanoma Cancer Market Segment by Application
11.1 Global Melanoma Cancer Revenue Market Share by Application (2015-2020)
11.2 Melanoma Cancer Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Cancer Research Centers Revenue Growth (2015-2020)
12 Global Melanoma Cancer Market Size Forecast (2021-2025)
12.1 Global Melanoma Cancer Market Size Forecast (2021-2025)
12.2 Global Melanoma Cancer Market Forecast by Regions (2021-2025)
12.3 North America Melanoma Cancer Revenue Market Forecast (2021-2025)
12.4 Europe Melanoma Cancer Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Melanoma Cancer Revenue Market Forecast (2021-2025)
12.6 South America Melanoma Cancer Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Melanoma Cancer Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Melanoma Cancer Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Melanoma Cancer by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Melanoma Cancer Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Melanoma Cancer Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. AB Sciences Corporate Information, Location and Competitors
Table 6. AB Sciences Melanoma Cancer Major Business
Table 7. AB Sciences Melanoma Cancer Total Revenue (USD Million) (2017-2018)
Table 8. AB Sciences SWOT Analysis
Table 9. AB Sciences Melanoma Cancer Product and Solutions
Table 10. AB Sciences Melanoma Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 12. Bristol-Myers Squibb Melanoma Cancer Major Business
Table 13. Bristol-Myers Squibb Melanoma Cancer Total Revenue (USD Million) (2018-2019)
Table 14. Bristol-Myers Squibb SWOT Analysis
Table 15. Bristol-Myers Squibb Melanoma Cancer Product and Solutions
Table 16. Bristol-Myers Squibb Melanoma Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Novartis Corporate Information, Location and Competitors
Table 18. Novartis Melanoma Cancer Major Business
Table 19. Novartis Melanoma Cancer Total Revenue (USD Million) (2017-2018)
Table 20. Novartis SWOT Analysis
Table 21. Novartis Melanoma Cancer Product and Solutions
Table 22. Novartis Melanoma Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Incyte Corporate Information, Location and Competitors
Table 24. Incyte Melanoma Cancer Major Business
Table 25. Incyte Melanoma Cancer Total Revenue (USD Million) (2017-2018)
Table 26. Incyte SWOT Analysis
Table 27. Incyte Melanoma Cancer Product and Solutions
Table 28. Incyte Melanoma Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. AstraZeneca Corporate Information, Location and Competitors
Table 30. AstraZeneca Melanoma Cancer Major Business
Table 31. AstraZeneca Melanoma Cancer Total Revenue (USD Million) (2017-2018)
Table 32. AstraZeneca SWOT Analysis
Table 33. AstraZeneca Melanoma Cancer Product and Solutions
Table 34. AstraZeneca Melanoma Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Merck Corporate Information, Location and Competitors
Table 36. Merck Melanoma Cancer Major Business
Table 37. Merck Melanoma Cancer Total Revenue (USD Million) (2017-2018)
Table 38. Merck SWOT Analysis
Table 39. Merck Melanoma Cancer Product and Solutions
Table 40. Merck Melanoma Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Amgen Corporate Information, Location and Competitors
Table 42. Amgen Melanoma Cancer Major Business
Table 43. Amgen Melanoma Cancer Total Revenue (USD Million) (2017-2018)
Table 44. Amgen SWOT Analysis
Table 45. Amgen Melanoma Cancer Product and Solutions
Table 46. Amgen Melanoma Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Pierre Fabre Corporate Information, Location and Competitors
Table 48. Pierre Fabre Melanoma Cancer Major Business
Table 49. Pierre Fabre Melanoma Cancer Total Revenue (USD Million) (2017-2018)
Table 50. Pierre Fabre SWOT Analysis
Table 51. Pierre Fabre Melanoma Cancer Product and Solutions
Table 52. Pierre Fabre Melanoma Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Daiichi Sankyo Corporate Information, Location and Competitors
Table 54. Daiichi Sankyo Melanoma Cancer Major Business
Table 55. Daiichi Sankyo Melanoma Cancer Total Revenue (USD Million) (2017-2018)
Table 56. Daiichi Sankyo SWOT Analysis
Table 57. Daiichi Sankyo Melanoma Cancer Product and Solutions
Table 58. Daiichi Sankyo Melanoma Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Melanoma Cancer Revenue (Million USD) by Players (2015-2020)
Table 60. Global Melanoma Cancer Revenue Share by Players (2015-2020)
Table 61. Global Melanoma Cancer Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Melanoma Cancer Revenue Market Share by Regions (2015-2020)
Table 63. North America Melanoma Cancer Revenue by Countries (2015-2020)
Table 64. North America Melanoma Cancer Revenue Market Share by Countries (2015-2020)
Table 65. Europe Melanoma Cancer Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Melanoma Cancer Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Melanoma Cancer Revenue by Countries (2015-2020)
Table 68. South America Melanoma Cancer Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Melanoma Cancer Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Melanoma Cancer Revenue Market Share by Countries (2015-2020)
Table 71. Global Melanoma Cancer Revenue (Million USD) by Type (2015-2020)
Table 72. Global Melanoma Cancer Revenue Share by Type (2015-2020)
Table 73. Global Melanoma Cancer Revenue Forecast by Type (2021-2025)
Table 74. Global Melanoma Cancer Revenue by Application (2015-2020)
Table 75. Global Melanoma Cancer Revenue Share by Application (2015-2020)
Table 76. Global Melanoma Cancer Revenue Forecast by Application (2021-2025)
Table 77. Global Melanoma Cancer Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Melanoma Cancer Picture
Figure 2. Global Melanoma Cancer Revenue Market Share by Type in 2019
Figure 3. Non-invasive melanoma Picture
Figure 4. Invasive melanoma Picture
Figure 5. Melanoma Cancer Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Cancer Research Centers Picture
Figure 8. Global Melanoma Cancer Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Melanoma Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Melanoma Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Melanoma Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Melanoma Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Melanoma Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Melanoma Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Melanoma Cancer Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Melanoma Cancer Revenue Market Share in 2019
Figure 17. Global Top 10 Players Melanoma Cancer Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Melanoma Cancer Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Melanoma Cancer Revenue Market Share by Regions (2015-2020)
Figure 21. Global Melanoma Cancer Revenue Market Share by Regions in 2018
Figure 22. North America Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 23. Europe Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 25. South America Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 27. North America Melanoma Cancer Revenue Market Share by Countries (2015-2020)
Figure 28. North America Melanoma Cancer Revenue Market Share by Countries in 2019
Figure 29. USA Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 30. Canada Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 32. Europe Melanoma Cancer Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Melanoma Cancer Revenue Market Share by Countries in 2019
Figure 34. Germany Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 35. UK Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 36. France Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 37. Russia Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 38. Italy Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Melanoma Cancer Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Melanoma Cancer Revenue Market Share by Countries in 2019
Figure 41. China Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 42. Japan Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 43. Korea Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 44. India Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 46. South America Melanoma Cancer Revenue Market Share by Countries (2015-2020)
Figure 47. South America Melanoma Cancer Revenue Market Share by Countries in 2019
Figure 48. Brazil Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Melanoma Cancer Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Melanoma Cancer Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 53. UAE Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Melanoma Cancer Revenue and Growth Rate (2015-2020)
Figure 56. Global Melanoma Cancer Revenue Share by Type (2015-2020)
Figure 57. Global Melanoma Cancer Revenue Share by Type in 2019
Figure 58. Global Melanoma Cancer Market Share Forecast by Type (2021-2025)
Figure 59. Global Non-invasive melanoma Revenue Growth Rate (2015-2020)
Figure 60. Global Invasive melanoma Revenue Growth Rate (2015-2020)
Figure 61. Global Melanoma Cancer Revenue Share by Application (2015-2020)
Figure 62. Global Melanoma Cancer Revenue Share by Application in 2019
Figure 63. Global Melanoma Cancer Market Share Forecast by Application (2021-2025)
Figure 64. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 65. Global Cancer Research Centers Revenue Growth Rate (2015-2020)
Figure 66. Global Melanoma Cancer Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Melanoma Cancer Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Melanoma Cancer Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Melanoma Cancer Revenue Market Forecast (2021-2025)
Figure 70. Europe Melanoma Cancer Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Melanoma Cancer Revenue Market Forecast (2021-2025)
Figure 72. South America Melanoma Cancer Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Melanoma Cancer Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
黒色腫治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Melanoma Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Melanoma Therapeutics m…- 皮膚がん診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Skin Cancer Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Skin Cancer Diagnosti…
- 皮膚ガンの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Skin Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.7% in the forecast period of 2020 to 2025 and will expected to reach USD 608.3 million by 2025, from USD 505.3 million in 2019. The Skin Cancer market report …
- 皮膚がん診断・治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Skin Cancer Diagnosis and Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Skin C…
- ペット用がん治療の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Pet Cancer Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.9% in the forecast period of 2020 to 2025 and will expected to reach USD 206.2 million by 2025, from USD 164.2 million in 2019. The Pet Cancer The…